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OBJECTIVE: We tracked various proficiency indicators for the learning curve as a single Taiwanese 
surgeon became familiar with robotic-assisted laparoscopic radical prostatectomy surgeries by performing
60 initial procedures.
METHODS: Between December 2005 and December 2007, 60 consecutive patients were classified into
Group 1 (Cases 1–30) or Group 2 (Cases 31–60). Pre-operative clinical characteristics, operative parame-
ters, and postoperative parameters were assessed. 
RESULTS: Pre-operative biopsy Gleason scores were significantly higher in Group 2 than in Group 1
(7.03 vs. 6.13, p < 0.01). The vesicourethral anastomosis time showed a statistically significant reduction
from 46.38 minutes in Group 1 to 31 minutes in Group 2 (p < 0.01). The continence rate at 3 months in
Group 2 was higher than that in Group 1 (97.6% vs. 76.7%, p = 0.052); the mean duration to continence
was shorter in Group 2 than Group 1 (70.26 ± 67.37 days vs. 39.63 ± 36.48 days, p = 0.056). Group 2 had
shorter postoperative stays (3.93 vs. 7.33) and longer durations of Foley catheter removal (9.0 vs. 7.7) than
Group 1, representing a statistically significant difference (p < 0.01).
CONCLUSION: After gaining experience by performing an initial 30 robotic-assisted laparoscopic radi-
cal prostatectomies, the subsequent 30 surgeries established proficiency as determined by vesicourethral
anastomosis time and early continence rate. [Asian J Surg 2011;34(2):74–80]
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Introduction
Prostate cancer is the most common cancer in the United
States. In Asia and Taiwan, there is a low incidence of clin-
ical prostate cancer; however, the incidence of prostate
cancer has been increasing in recent years.1,2 Prostate can-
cer is ranked fifth among the most common male malig-
nancies in Taiwan. The mortality rate has been increasing
along with the incidence because most cases are diag-
nosed at advanced stages. Clinical T1c prostate cancer
accounts for 25% of localised prostate cancer surgeries.3
The da Vinci robotic surgery system for urological
applications was introduced in 1999. The da Vinci system
(Intuitive Surgical, Inc.; Sunnyvale, CA, USA) offers sev-
eral technical advantages for the surgeon, including intuitive
finger-controlled movements, 10 times magnification,
three-dimensional stereoscopic optics, computer elimina-
tion of tremor, end-of-wrist instrument with seven degrees
of freedom of range of motion, and scaled-down move-
ment. Since the first robotic-assisted laparoscopic radical
prostatectomy (RALP) was performed by Binder and
Kramer4 in Frankfurt in May 2000, use of the technique
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has been increasing worldwide as the preferred surgical
treatment for localised prostate cancer. In 2006, over
30,000 robotic prostatectomies were performed, and it is
estimated that 48,000 such surgeries (approximately 60%
of all radical prostatectomies) were performed in 2007.5,6
However, RALP is still in its infancy in Taiwan. In Taiwan,
six da Vinci surgical systems have been acquired since
October 2004. Dr Patel has reported that the initial expe-
rience with robotic radical prostatectomy is promising
with a learning curve of approximately 20–25 cases required
to achieve proficiency.5 We previously reported changes
in indicators of proficiency and short-term outcomes
during our experience with an initial 30 cases of RALP
performed by a single surgeon; we established proficiency
as determined by functional outcomes required approxi-
mately 30 cases.1 We herein report our experience with an
initial 60 cases and the associated learning curve and
short-term outcomes of RALP as performed by a single
surgeon.
Patients and methods
Between December 2005 and December 2007, 60 patients
with prostate cancer underwent RALP performed by a sin-
gle surgeon in our institution. The consecutive patients
were divided into two groups classified as Group 1 and
Group 2: Group 1 comprised the 1st through 30th cases and
Group 2 the 31st through 60th cases. Preoperative clinical
characteristics were recorded, including age, body mass
index, American Society of Anesthesiologists anaesthetic/
surgical risk class, prostate-specific antigen (PSA) levels,
free PSA ratio, PSA density, biopsy percentage, biopsy
Gleason score, and clinical stage.
Surgical procedure
Our da Vinci robotic training course under Dr Patel was
completed at Ohio State University, USA, in October
2005.1 We keep in touch with our mentor Dr Patel to dis-
cuss more details, pitfalls, and tips on performing RALP.
The robotic team included a console surgeon, two clinical
fellows, one circulating nurse, two scrub nurses, and an
Intuitive Surgical Taiwan representative. We performed
the RALP procedure as previously described.1 We imitated
Patel’s way of performing RALP with minor modifica-
tions.6,7 From cases one to six, a four-arm approach was
taken; from case seven onward, we took a three-arm
approach with five trocars. The biggest difference between
Groups 1 and 2 was in the manner of dealing with the
puboprostatic ligaments and dorsal vein complex (DVC).
In Group 1, the bilateral puboprostatic ligaments were
preserved and the DVC was ligated with one sutured
stitch (1-0 vicryl); no placement of a second suture for
venous backflow or suspension of the DVC was performed.
In Group 2, the bilateral puboprostatic ligaments were
excised and the DVC was ligated with one sutured stitch
(1-0 vicryl); we then placed a second suture (3-0 Monocryl)
to secure the DVC to the pubic bone. Another suture (1-0
vicryl) was placed at the anterior prostate capsule for
venous backflow. Dissection of the bilateral pelvic lymph
nodes and bilateral neurovascular preservation proce-
dures were discretionary and were determined according
to the pre-operative tumour status and intra-operative
conditions. Urethrovesical anastomosis using two 16-cm
3-0 Monocryl continuous stitches was performed using
the Van Velthoven technique.8 An 18-French silicon Foley
catheter with a 10-mL balloon was inserted. The urinary
bladder was then injected intra-operatively with 200 mL
normal saline to confirm that there was no leakage.
Data collection
Proficiency indicators were recorded for each surgery,
including whether bilateral pelvic lymph node dissection
or neurovascular bundle preservation (NVB) were per-
formed, the surgeon’s console time, vesicourethral anas-
tomosis time, estimated blood loss, transfusion rate,
intra-operative and postoperative complication and con-
version rates, and whether a postoperative cystogram was
performed. Console time was defined as the time when
the surgeon was at the console using the da Vinci instru-
ment from the dropping of the urinary bladder to vesi-
courethral anastomosis. The operating time was variable
with different assistants because of differences in the
times required to set up trocars, dock the da Vinci, and
remove the specimen.
Radical prostatectomy specimens were fixed, coated
with Indian ink, and cut into sequential stepwise sections
at 4-mm intervals.3 The Gleason score, positive surgical
margin (PSM) rate, specimen volume, tumour volume,
tumour percentage, and node positive rate were recorded. 
Postoperative care
Postoperatively, patients were encouraged to ambulate on
postoperative day (POD) 1 or 2. Patients were permitted
to have sips of water and then resume a regular diet on
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POD 1 or 2. The closed wound drainage tube was removed
on POD 1 to 3. The intravenous fluid was discontinued
on POD 1–3. Patients were hospitalised until removal of
the Foley catheter at 7 days after surgery in Group 1.
Patients were discharged early and arrangements were
made to remove Foley catheters at 7–14 days after surgery.
Continence was defined as achieving the use of no pads
or only one “security” pad daily. Patients were followed up
in outpatient clinics at 1 week and 1 month, and then every
3 months after discharge to evaluate urination, sexual
function, and PSA level. We defined PSA or biochemical
failure as two serial serum PSA results of > 0.2 ng/mL.3
Statistical analysis
All data are expressed as mean ± standard deviation. The
SPSS 12.0 for Windows program package (SPSS Inc.,
Chicago, IL, USA) was used for basic statistical calcula-
tions. Statistical analysis was performed using the non-
parametric Mann-Whitney U test, Fisher’s exact test, and
Yate’s correction of the contingency test as appropriate. 
A p value of less than 0.05 was considered statistically 
significant.
Results
Operation outcome
We performed RALP on 60 patients and evaluated profi-
ciency as the surgeon’s experience with the technique
increased. Patients in Group 2 had higher biopsy Gleason
scores than Group 1 (7.03 ± 1.16 vs. 6.13 ± 0.90, respec-
tively), (p < 0.01), and Group 2 had higher pathological
Gleason scores (8–10) than Group 1 (30% vs. 6.7%) (Table 1).
Group 2 also had higher PSA levels and biopsy tumour
percentages than Group 1 although these results were not
statistically significant. Table 2 demonstrates the pro-
ficiency gained over the second course of 30 RALP sur-
geries as measured by various procedural indicators. 
For example, Group 1 patients were evaluated by cys-
togram more frequently than those in Group 2 (43.30% vs.
0%, p < 0.01) before removal of the urethral catheter.
Anastomosis time was the second parameter showing a
significant difference: 46.38 ± 15.41 minutes for Group 1
and 31.00 ± 7.36 minutes for Group 2 (p < 0.01). Group 2
also had lower console times, blood loss, and transfusion
rates than Group 1, but these were not statistically signif-
icant. No significant differences were observed between
the groups in the incidence of bilateral pelvic lymph node
dissection and NVB. Complications were noted in 5 of the
30 patients (16.7%) in Group 1, including urinary bladder
injury with intra-operative repair in two cases, vesico-
urethral anastomosis tear in one case, and intra-operative
bleeding in one case; these two cases were converted to a
mini-laparotomy (5 cm) for repair and to check bleeding.
One patient experienced a mild vesicourethral anastomosis
stricture at 2 months after surgery. Complications were
noted in 3 of the 30 patients (10%) in Group 2, including
intra-operative bleeding that required mini-laparotomy
(5 cm) to check bleeding in one case, mild vesicourethral
anastomosis stricture at 4 months postoperatively in one
case, and mild urethral meatal stricture in one case.
Table 1. Pre-operative clinical characteristics of initial 60 cases
of robotic-assisted radical prostatectomy
Clinical data
Group 1: Group 2: 
Cases 1–30 Cases 31–60
Age (yr) 67.27 ± 6.21 63.83 ± 7.34 
BMI 24.22 ± 3.15 24.78 ± 2.51
ASA (I/II/III) 5/15/10 8/18/4
PSA (ng/mL) 16.46 ± 18.80 17.31 ± 19.00
PSA density 0.47 ± 0.43 0.47 ± 0.51
Biopsy percentage 15.88% ± 10.47% 21.68% ± 18.87%
Biopsy Gleason score 6.13 ± 0.90 7.03 ± 1.16†
2–4/5–7/8–10 2/26/2 0/21/9*
Clinical stage 15/15/0 11/17/2
(T1/T2/T3)
*p < 0.05; †p < 0.01. BMI = body mass index; ASA = American Society
of Anesthesiologists anaesthetic/surgical risk class; PSA = prostate-
specific antigen; PSA density = PSA/prostate volume by transrectal
sonography.
Table 2. Operation parameters of initial 60 cases of robotic-
assisted radical prostatectomy
Factors
Group 1: Group 2: 
Cases 1–30 Cases 31–60
Console time (hr) 3.75 ± 1.62 3.15 ± 0.58
BPLND 22/30 (73.3%) 21/30 (70.0%)
NVB preservation 16/30 (53.3%) 14/30 (46.7%)
Anastomosis time (min) 46.38 ± 15.41 31.00 ± 7.36*
Blood loss (mL) 314.83 ± 284.05 227.33 ± 176.16
Transfusion rate 4/30 (13.3%) 0/30 (0%)
Complications 5/30 (16.7%) 3/30 (10%)
Cystogram 13/30 (43.3%) 0/30 (0%)*
*p < 0.01. NVB = neurovascular bundle; BPLND = bilateral pelvic
lymph node dissection.
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Oncologic outcomes
Table 3 shows the clinical and pathologic outcomes for
the 60 patients. Group 2 patients had significantly shorter
postoperative stays and longer catheterisation times than
Group 1 (p < 0.01). Group 2 had poorer pathological fac-
tors than Group 1, including tumour volume, tumour
percentage, Gleason pathology score, and node-positive
rates. No statistically significant differences were found.
The PSM rate and PSA failure rate between the two groups
were similar. Postoperatively, patients with PSM underwent
no adjuvant radiation or hormonal therapy. Salvage radi-
ation was adopted if PSA double time was greater than 
6 months. Patient received salvage hormonal therapy if
PSA double time was less than 6 months. Later, PSA failure
developed in 10 patients; of these, five underwent salvage
radiation and five underwent salvage hormonal therapy.
Functional outcomes
The continence rate at 3 months in Group 2 was higher
than that in Group 1 (97.6% vs. 76.7%, p = 0.052), and the
mean duration to continence was shorter in Group 2 than
in Group 1 (70.26 ± 67.37 vs. 39.63 ± 36.48 days, p = 0.056).
The long-term continence rate at 12 months was 100% in
both groups. Sexual function outcomes at 12 months,
including potency and intercourse, were similar in both
groups (Table 4).
Discussion
The prevalence of clinical prostate cancers between Asians
and whites are quite different; however, the incidence of
latent prostate cancer in Taiwan is 33%, similar to that in
Japan and the United States.9−11 Years ago, prostate can-
cer in Taiwan had a low incidence and mortality rate, but
these rates have risen rapidly in the past 2 decades according
to data from the Health and National Health Insurance
Annual Statistics Information Service of Taiwan (http://
www.doh.gov.tw/statistic/index.htm). The incidence has
increased 16.13-fold from 1.45/100,000 in 1981 to 23.39/
100,000 in 2005. Prostate cancer is currently ranked fifth
among male malignancies in Taiwan. The mortality rate
increased 10.75-fold from 0.8/100,000 in 1981 to 8.6/
100,000 in 2007. Brawley et al12 reported that countries in
which dietary fat intake is greater have been shown to
have higher prostate cancer mortality rates. This has led
some to conclude that dietary fat causes prostate cancer.
Pu et al2 described an increase in fat consumption of 35%
from 97 g/day in 1987 to 131 g/day in 1997 in Taiwan.
This evidence supports the idea that environmental and
lifestyle factors contribute to increasing the incidence and
mortality rates of prostate cancer in Taiwan. Another
explanation is that community-based screening conducted
at medical centres in Taiwan in recent years have reported
an overall detection rate of approximately 1%.3,13
Table 3. Postoperative parameters of initial 60 cases of robotic-
assisted radical prostatectomy
Factors
Group 1: Group 2: 
Cases 1–30 Cases 31–60
Foley catheter (d) 7.70 ± 2.09 9.00 ± 2.21*
Postoperative stay (d) 7.33 ± 2.32 3.93 ± 1.55*
Surgical margin 15/30 (50%) 13/30 (43.3%)
positive
pT2 2/15 (13.3%) 1/14 (7.1%)
pT3 13/15 (86.7%) 12/16 (75.0%)
Specimen volume (mL) 40.23 ± 16.71 43.30 ± 15.00
Tumour volume 8.76 ± 7.97 10.54 ± 9.41
Tumour percentage 21.44% ± 17.78% 27.80% ± 27.53%
Pathology Gleason 7.10 ± 1.12 7.20 ± 1.06
score
2–4/5–7/8–10 0/24/6 0/22/8
Node-positive 2/30 (6.7%) 3/30 (10%)
PSA failure at 6/30 (20%) 4/30 (13.3%)
15 months
*p< 0.01. PSA = prostate-specific antigen.
Table 4. Continence and sexual function outcomes in initial 60
cases of robotic-assisted radical prostatectomy 
Factors
Group 1: Group 2: 
Cases 1–30 Cases 31–60
Continence (d) 70.26 ± 67.37 39.63 ± 36.48*
within 1 wk 6 (20%) 11 (36.7%)
at 3 mo 23 (76.7%) 29 (96.6%)†
at 6 mo 29 (96.7%) 30 (100%) 
at 12 mo 30 (100%) 30 (100%)
Potency at 12 mo 14/16 (87.5%) 11/14 (78.6%)
Bilateral NVB 11/11 (100%) 7/7 (100%)
Unilateral NVB 3/5 (60%) 4/7 (57.1%)
Intercourse at 12 mo 10/16 (62.5%) 8/14 (57.1%)
Bilateral NVB 9/11 (81.8%) 6/7 (85.7%)
Unilateral NVB 1/5 (20%) 2/7 (28.6%)
*p= 0.056; †p= 0.052. NVB = neurovascular bundle preservation.
Previously, we reported that the short-term outcomes
of robotic-assisted radical prostatectomy in Taiwan have
confirmed that a learning period of approximately 30 sur-
geries is required to attain basic proficiency.1 In the pres-
ent study, comparisons were made between the first 30
cases and the second 30 cases. A single surgeon performed
the surgeries in this study to eliminate the variability in
learning curves among different surgeons. Patel’s pro-
cedure was followed to facilitate rapid assimilation of 
the technical aspects of the robotic approach. It was very
important for us to copy their steps entirely as a standard
reference with only minor modifications. Over a 36-month
period, this surgeon performed 113 of the 150 RALPs per-
formed in this hospital. The anastomosis time was one of
the parameters that improved significantly between the
initial and later surgeries. In our study, the vesicourethral
anastomosis time declined from 46 minutes for the first
15 cases to 31 minutes, representing a significant differ-
ence. Ahlering et al14 reported an anastomosis time of 50
minutes for cases 1–5, 47 minutes for cases 6–10, 36 min-
utes for cases 11–20, 27 minutes for cases 21–35, and 21
minutes for cases 36–45. In our study, the vesicourethral
anastomosis time decreased from 52 minutes for cases
1–15, 41 minutes for cases 16–30, 31.6 minutes for cases
31–45, and 30.3 minutes for cases 46–60. Anastomosis
times were not markedly improved because reconstruc-
tion of the bladder neck was necessary in several cases.
More experience in dissection of the delicate bladder neck
and skilful suturing is needed to achieve a rapid anasto-
mosis time. Our console time was 3.75 hours for the first
30 cases; it decreased to 3.15 hours for the second 30 cases.
It was not markedly shortened because more detailed,
time-consuming procedures were required in the second
30 cases, such as neurovascular nerve preserving and apex
dissection. We found that the times for setup of the da
Vinci system, trocar insertion, removal of the specimen,
and wound closure gradually decreased as the assistant’s
experience increased. We did not measure the total time
because of inherent bias in the use of different assistants.
Another significant marker of proficiency that we observed
was the rate of performance of a postoperative cystogram
to check for anastomosis leakage, which decreased from
43.3% to 0%.
The tamponade effect prevents venous bleeding dur-
ing pneumoperitoneum of approximately 12–15 mmHg
during RALP. The mean estimated blood loss in studies re-
ported in the literature is 75–900 mL.1,5,6,14–18 Predictably,
the reported transfusion rate ranged from 0% to 16.6%,
with no transfusions needed in the initial experience
reported for several studies.1,5,6,14–18 In our study, the
blood loss and transfusion rate declined from 314 mL and
13.30% in the first 30 cases to 227 mL and 0% in the sub-
sequent 30 cases, respectively.
The greatest advantage of RALP is rapid recuperation
and a very short hospital stay. Patel15 reviewed the length
of hospital stay for RALP and reported only 1.08–5.5 days
in one study and 1.08–1.5 days in another recent study in
the United States. In our series, postoperative hospitalisa-
tion was shortened from 7.33 days for the initial 30 cases
to 3.93 days for the subsequent 30 cases.
An additional benefit of RALP is better continence
rates and an earlier return of continence because of improved
preservation of the urethral sphincter and urethral length.
A high-quality, three-dimensional endoscopic camera in
the da Vinci system provides better visualisation of the
apex, allowing the surgeon to finely dissect and preserve
the urethral sphincter.19 Pasticier et al20 reported that
80% of patients had continence at 9 days. Ahlering et al14
reported continence rates of 33%, 63%, and 81% at 1 week,
1 month, and 3 months after RALP, respectively. Patel 
et al5 reported continence rates of 47%, 82%, 89%, 92%,
and 98% at 1, 3, 6, 9, and 12 months, respectively. In our
first 30 cases, the continence rates were 20%, 76.7%, 96.7%,
and 100% at 1 week and 3, 6, and 12 months after RALP,
respectively. In the subsequent 30 cases, the continence
rates were 36.7%, 96.6%, and 100% at 1 week and 3 and 
6 months. The continence rate at 3 months in the subse-
quent 30 cases (Group 2) was higher than in the first 30
cases (Group 1) (97.6% vs. 76.7%, p = 0.052); the mean
duration to continence was shorter in Group 2 than in
Group 1 (70.26 ± 67.37 d vs. 39.63 ± 36.48 d, p = 0.056).
The time to return of continence was obviously shortened
although the p value did not indicate a statistically signif-
icant difference because of the limited number of cases.
The parameters of continence rate included perioperative
factors (body weight, patient age, and prostate volume),
anatomical factors (puboperinealis muscle-sparing dissec-
tion, trigonal denervation, and preservation of endopelvic
fascia), and technical factors (bladder neck preservation,
urethral length preservation, mucosal eversion, NVB preser-
vation, and puboprostatic ligament preservation).20 The
probable reason for the relatively good continence results
in the initial group (Group 1) is that the puboprostatic
ligament-sparing technique in our modified procedure
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improves the speed of return of urinary continence after
radical prostatectomy. Poore et al21 reported that the
median time until continence was achieved after surgery
was significantly shorter (p = 0.01) for the puboprostatic
ligament-sparing group than for the standard method
(6.5 and 12 weeks, respectively). Stolzenburg et al22 also
showed that nerve-sparing endoscopic extraperitoneal
radical prostatectomy with preservation of the pubopro-
static ligaments was able to ascertain recuperation of
early continence more than nerve-sparing radical prosta-
tectomy without preservation of the puboprostatic liga-
ments. Both of these studies reported that the puboprostatic
ligament-sparing technique improves the rapidity of return
of urinary continence without significantly interfering
with surgical margins.22,23 The biggest difference between
Groups 1 and 2 involved the puboprostatic ligaments and
the DVC: Group 1, preservation of puboprostatic liga-
ments; Group 2, suspension of the DVC. Patel’s procedure
taught us to divide the puboprostatic ligaments and sus-
pend the DVC. Cold scissors were used to divide the urethra,
developing a long urethral stump that facilitated vesi-
courethral anastomosis.7 The evidence of our results show
that preservation of a longer urethral length improved the
continence rate at 3 months and shortened the time to
continence by about 30 days. Patel et al24 prospectively
analysed 331 consecutive patients who underwent RALP;
94 without the placement of a suspension stitch (Group
1) and 237 with the application of a suspension stitch
(Group 2). The suspension stitch during RALP resulted in
statistically significantly higher continence rates (92.8%
for Group 1 vs. 83% for Group 2) at 3 months after the
procedure.24 The preservation of adequate urethral sphinc-
ter length is crucial to maintain the continence mecha-
nism after open radical prostatectomy.25,26 Paparel et al19
compared the change in membranous urethral length
postoperatively and pre-operatively using endorectal mag-
netic resonance imaging as a measure of recovery time
and level of urinary continence after radical prostatectomy.
It is also possible that improvement in the recovery of the
continence interval was related to the progression of sur-
gical dissection skills to be able to avoid damage to the
urethral sphincter.
In our study, the incidence of bilateral or unilateral
NVB preservation was similar in both groups, and the
potency and intercourse rate at 12 months were also simi-
lar. The overall incidence of NVB preservation was 50%.
The overall potency rate was 83.3%; 100% for bilateral
NVB preservation and 58.3% for unilateral NVB preserva-
tion. The overall intercourse rate at 12 months was 60%;
83.3% for bilateral NVB preservation and 25% for unilat-
eral NVB preservation. The factors that influence erectile
function include previous sexual function, age, and intra-
operative injury of the NVB. Menon et al27 reported
potency and intercourse rates of 82% and 64% in patients
younger than 60 years of age, and 75% and 38% in patients
older than 60 years, respectively. Recently, the new tech-
nique of prostatic fascia preservation and athermal
robotic techniques to avoid neurovascular injury have
resulted in better potency rates of up to 97% at the 1-year
follow-up.28,29
With respect to oncological outcomes, the overall
PSM was 46.7%. It decreased slightly from 13.3% to 7.1%
for patients at pathological stage T2 and from 86.7% to
75% for patients at pathologic stage T3. We also observed
a 16.6% PSA failure rate at 15 months related to more
advanced tumours, inadequate surgical margins, and
occult pelvic lymph node metastasis. In Patel’s review, the
PSM rate range was 0% to 20% for patients at T2 and 0%
to 75% for T3.15 Ahlering et al30 reported one surgeon’s
outcomes from 60 RALP procedures in which the PSM
rate for pathological stages > T3 was 50%. Atug et al29
reported that the PSM tended to diminish from 45.4%,
21.2% to 11.7% as the surgeon’s experience increased over
approximately 30 cases. Reducing the PSM rate is undoubt-
edly a challenge for the novice during experience with the
initial 60 cases. We conclude that improvement in the sur-
geon’s technique is the best way to reduce PSM and PSA
failure rates, and that more than 60 cases are needed 
to improve oncological outcomes. The learning curve of
RALP was nerve-defined. The surgeon with a low surgical
volume of retropubic prostatectomy (RRP) will find it easier
to achieve this standard. However, surgeons with exten-
sive experience with RRP may “set the bar” higher for the
learning curve because of having higher expectations.31
Dr Smith reported that RALP results comparable with
those obtained routinely with RRP were not achieved
until after more than 150 procedures.31 Surgeon comfort
and confidence comparable with that with RRP did not
occur until 250 RALP procedures had been performed.31
In summary, after experience performing an initial 30
robotic-assisted laparoscopic radical prostatectomies by a
single surgeon, the subsequent 30 surgeries established
proficiency as determined by vesicourethral anastomosis
time and early continence rate.
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